Acorda Therapeutics Number of Employees 2010-2023 | ACOR
Acorda Therapeutics number of employees from 2010 to 2023. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Acorda Therapeutics Annual Number of Employees |
| 2022 |
122 |
| 2021 |
130 |
| 2020 |
168 |
| 2019 |
344 |
| 2018 |
474 |
| 2017 |
484 |
| 2016 |
597 |
| 2015 |
535 |
| 2014 |
489 |
| 2013 |
421 |
| 2012 |
378 |
| 2011 |
328 |
| 2010 |
305 |
| 2009 |
249 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.012B |
$0.119B |
|
Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA? (dalfampridine) Extended Release Tablets, 10 mg.
|
